SEC Form 4 · accession 0001140361-15-045458
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward L. Field
Officer — President brtxDISC Division
Period of report
Dec 22, 2015
Accepted (ET)
Dec 23, 2015 · 11:32 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF2,F3 | $7.00 | Dec 22, 2015 | A | 25,000 | A | — | Sep 4, 2025 | Common Stock | 25,000 | 25,000 | D |
| OptionF1 | $9.20 | holding | — | — | — | — | Feb 9, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests to the extent of 8,334 shares on February 9, 2016 and 8,333 shares on each of February 9, 2017 and February 9, 2018.
- F2On December 22, 2015 the stockholders of the Issuer approved amendments to the Issuer's 2010 Equity Participation Plan (the "Plan") to increase the number of shares authorized to be issued pursuant to the Plan to 2,250,000. The Reporting Person had been granted the option on September 4, 2015, subject to stockholder approval of such amendments.
- F3The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018.